Infectious Disease Division, Winthrop-University Hospital, 22 Station Plaza North (#432), Mineola, NY, 11501, USA.
School of Medicine, State University of New York, Stony Brook, NY, USA.
Eur J Clin Microbiol Infect Dis. 2018 Jan;37(1):15-20. doi: 10.1007/s10096-017-3081-x. Epub 2017 Aug 17.
Doxycycline and, to a lesser extent, minocycline, have been used for decades to treat various serious systemic infections, but many physicians remain unfamiliar with their spectrum, interpretation of susceptibility results, pharmacokinetic/pharmacodynamic (PK/PD) properties, optimal dosing regimens, and their activity against MRSA, VRE, and multidrug-resistant (MDR) Gram-negative bacilli, e.g., Acinetobacter sp. This article reviews the optimal use of doxycycline and minocycline to treat a variety of infections and when minocycline is preferred instead of doxycycline.
多西环素和米诺环素已被使用了几十年,用于治疗各种严重的全身感染,但许多医生对它们的光谱、药敏结果的解读、药代动力学/药效学(PK/PD)特性、最佳给药方案以及它们对耐甲氧西林金黄色葡萄球菌(MRSA)、万古霉素耐药肠球菌(VRE)和多种耐药(MDR)革兰氏阴性杆菌(如不动杆菌属)的活性仍然不熟悉。本文回顾了多西环素和米诺环素治疗各种感染的最佳应用,以及何时应优先使用米诺环素而非多西环素。